Abstract
The metabolic consequences of the actions of catecholamines on the heart have been excellently reviewed by Himms-Hagen in Vol. XXXIII. of this Handbook (Himms- Hagen, 1972). Therefore, the effects of adrenergic agonists on heart metabolism will be discussed rather briefly and attention will be focussed on new problems which have arisen and are under investigation. Progress during the last years consists of better knowledge of the molecular nature of the processes which originate on the cell surface membrane by interaction of adrenergic agonists with their specific receptors and which terminate in a modified physiological response. The first series of the cascading chain reactions which result in an increased intracellular level of cyclic AMP is based on the “second messenger” concept postulated by Sutherland and co-workers (Sutherland and Rall, 1960; Sutherland et al., 1965; Sutherland and Robison, 1966; Sutherland et al., 1968). The role of cyclic AMP in mediating metabolic and physiological effects of catecholamines, which represent the naturally occurring class of adrenergic agonists, is now clearer. However, it is far from being completely understood. Recently published results of Ingebretsen et al., Becker et al., and Hu and Venter have demonstrated that catecholamines covalently bound to glass beads or polymers are able to induce metabolic and physiological effects comparable to those of solubilized amines without, however, raising the intracellular level of cyclic AMP (Ingebretsen et al., 1977; Becker et al., 1977; Hu and Venter, 1978). How the signal originating from interaction of catecholamines with the β-adrenergic receptor is propagated is obscure and has still to be clarified.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abe, K., Robison, G.A., Liddle, G.W., Butcher, R.W., Nicholson, W.E., Baird, C.E.: Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonine on frog skin color. Endocrinol. 85, 674–682 (1969)
Ahlquist, R.P.: A study of the adrenotropic receptors. Am. J. Physiol. 153, 586–600 (1948)
Alexander, R.W., Williams, L.T., Lefkowitz, R.J.: Identification of cardiac β-adrenergic receptors by (-) [3H]alprenolol binding. Proc. Natl. Acad. Sci. 72, 1564–1568 (1975)
Amer, M.S.: Guanosine 3’,5’-monophosphate and gallbladder contraction. Gastroenterol. 67, 333–337 (1974)
Appleman, M.M., Thompson, W.J., Russell, T.R.: Cyclic nucleotide phosphodiesterases. Adv. Cycl. Nucl. Res. 3, 65–98 (1973)
Appleman, M.M., Terasaki, W.L.: Regulation of cyclic nucleotide phosphodiesterase. Adv. Cycl. Nucl. Res. 5, 153–162 (1975)
Avdonin, P.W., Tkatschuk, W.A.: Uschastije Ca2+ sawizimovo aktivatora w regulatzii aktivnosti adenylatcyklasi zerdza ionami Ca. Doklady Akademii Nauk SSSR 238, 726–729 (1978)
Axelrod, J.: Regulation of catecholamine neurotransmitters, metabolism and β-adrenergic receptors. Abstr. 2726 of 7th Int. Congr. Pharmacol., Paris 1978
Ballard, F.B., Danforth, W.H., Naegk, S., Bing, R.J.: Myocardial metabolism of fatty acids. J. Clin. Invest. 39, 717–723 (1960)
Banerjee, S.P., Kung, L. S.: β-adrenergic receptors in rat heart: effects of thyreodectomy. Europ. J. Pharmacol. 43, 207–208 (1977)
Barnett, R.E.: Fluidity in membranes. In: Receptors and Hormone Action. Vol. 1. Edit. B.W. O’Malley and L. Birnbaumer. New York, San Francisco, London: Academic Press 1977, pp. 427–446
Beavo, J.A., Bechtel, P.J., Krebs, E.G.: Activation of protein kinase by physiological concentrations of cyclic AMP. Proc. Natl. Acad. Sci. 71, 3580–3583 (1974)
Bechtel, P.J., Beavo, J.A., Hofman, F., Dills, W.L., Krebs, E.G.: Cyclic AMP-dependent protein kinase isoenzymes. Fed. Proc. 34, 617 (1975)
Becker, E., Ingebretsen, W.R., Jr., Mayer, S.E.: Electrophysiological responses of cardiac muscle to isoproterenol covalently linked to glass beads. Circul. Res. 41, 653–660 (1977)
Benfey, B.G.: Characterization of a-adrenoceptors in the myocardium. Brit. J. Pharmacol. 48, 132–138 (1973)
Benfey, B.G.: Cardiac adrenoceptors at low temperature: What is the experimental evidence for the adrenoceptor interconversion hypothesis? Fed. Proc. 36, 2575–2579 (1977 a)
Benfey, B.G.: Cardiac adrenoceptors at low temperature and the adrenoceptor interconversion hypothesis. Brit. J. Pharmacol. 61, 167–173 (1977 b)
Bensadoun, A., Ehnholm, C., Steinberg, D., Brown, W.V.: Purification and characterization of lipoprotein lipase from pig adipose tissue. J. Biol. Chem. 249, 2220–2227 (1974)
Berridge, M.J.: The interaction of cyclic nucleotides and calcium in the control of cellular activity. Adv. Cycl. Nucl. Res. Vol. 6, edited by P. Greengard and G. A. Robinson. New York: Raven Press 1975, pp. 1–80
Berridge, M.J., Rapp, P.: Cyclic nucaleotides, calcium and cellular control mechanisms. In: Cyclic 3’,5’-nucleotides: Mechanism of action. Edit. H. Cramer and J. Schultz. London, New York, Sidney, Toronto: John Wiley & Sons 1977, pp. 65–76
Birnbaumer, L.: Regulatory events at the level of membrane-bound adenylate cyclase. In: Cyclic 3’,5’-nucleotides: Mechanism of action. Edit. H. Cramer and J. Schultz. London, New York, Sidney, Toronto: John Wiley & Sons 1977, pp. 13–37
Blumenthal, D.K., Stull, J.T., Gill, G.N.: Phosphorylation of cardiac troponin by guanosine 3’:5’-monophosphate-dependent protein kinase. J. Biol. Chem. 253, 334–336 (1978)
Brostrom, M.A., Reimann, E.M., Walsh, D.A., Krebs, E.G.: A cyclic AMP-stimulated protein kinase from cardiac muscle. Adv. Enzyme Regul. 8, 191–203 (1970)
Brostrom, C.O., Huang, Y.-C., Breckenridge, B.M., Wolff, D.J.: Identification of a calcium binding protein as a calcium dependent regulator of brain adenylate cyclase. Proc. Natl. Acad. Sci. USA 72, 64–68 (1975)
Burns, T.W., Langley, P.E.: The effect of alpha and beta adrenergic receptor stimulation on the adenylate cyclase activity of human adipocytes. J. Cycl. Nucl. Res. 1, 321–328 (1975)
Caron, M.G., Lefkowitz, R.J.: Solubilization and characterization of the β-adrenergic receptor binding sites of frog erythrocytes. J. Biol. Chem. 251, 2374–2384 (1976)
Casti, A., Corti, A., Reali, N., Mezzetti, G., Orlandini, G., Caldarera, C.M.: Modifications of major aspects of myocardial ribonucleic acid metabolism as a response to noradrenaline. Behaviour of polyadenylate polymerase and ribonucleic acid polymerase, acetylation of histones and rate of synthesis of polymerases. Biochem. J. 168, 333–340 (1977)
Challoner, D.R., Steinberg, D.: Metabolic effect of epinephrine on the QO2 of the arrested isolated perfused rat heart. Nature (London) 205, 602–603 (1965)
Cheung, W.Y.: Cyclic 3’,5’-nucleotide phosphodiesterase: Demonstration of an activator. Biochem. Biophys. Res. Commun. 38, 533–538 (1970)
Cheung, W.Y.: Cyclic 3’,5’-nucleotide phosphodiesterase: Evidence for and properties of a protein activator. J. Biol. Chem. 246, 2859–2869 (1971)
Christian, D.R., Kilsheimer, G.S., Pettett, G., Paradise, R., Ashmore, J.: Regulation of lipolysis in cardiac muscle: A system similar to the hormone sensitive lipase of adipose tissue. Adv. Enzyme Regul. 7, 71–82 (1969)
Chubb, J., Huxtable, R.: Isoproterenol-stimulated taurine influx in the perfused rat heart. Europ. J. Pharmacol. 48, 369–376 (1978)
Chubb, J., Byus, C., Russell, D.H., Huxtable, R.: Cyclic AMP-dependent protein kinases in isoproterenol-induced cardiac hypertrophy. Fed. Proc. 35, 288 (1976)
Ciaraldi, T., Marinetti, G.V.: Thyroxine and propylthiouracil effects in vivo on alpha and beta adrenergic receptors in rat heart. Biochem. Biophys. Res. Commun. 74, 984–991 (1977)
Claycomb, W.C.: Biochemical aspects of cardiac muscle differentiation. Control of DNS synthesis and cell differentiation by adrenergic innervation and cyclic adenosine 3’,5’-monophosphate. J. Biol. Chem. 251, 6082–6090 (1976)
Claycomb, W.C.: Cardiac muscle hypertrophy. Differentation and growth of the heart cell during development. Biochem. J. 168, 599–601 (1977)
Cohen, P.: Oral presentation. 12th Febs Meeting 1978 Dresden.
Cole, H.A., Perry, S.V.: The phosphorylation of troponin I from cardiac muscle. Biochem. J. 149, 525–533 (1975)
Coleman, A.J., Somerville, A.R.: The selective action of β-adrenoceptor blocking drugs and the nature of β1 and β2 adrenoceptors. Brit. J. Pharmacol. 59, 83–93 (1977)
Corbin, J.D., Keely, S.L.: Characterization and regulation of heart adenosine 3’,5’-monophosphate-dependent protein kinase isozymes. J. Biol. Chem. 252, 910–918)(1977a)
Corbin, J.D., Sugden, P.H., Lincoln, T.M., Keely, S.L.: Compartmentalization of adenosine 3’:5’-monophosphate and adenosine 3’:5’-monophosphate-dependent protein kinase in heart tissue. J. Biol. Chem. 252, 385–3861 (1977 b)
Corbin, J.D., Keely, S.L., Park, R.C.: The distribution and dissociation of cyclic adenosine 3’,5’-monophosphate-dependent protein kinases in adipose, cardiac and other tissues. J. Biol. Chem. 250, 218–225 (1975)
Corti, A., Casti, A., Mezzetti, G., Reali, N., Orlandini, G., Caldarera, C.M.: Modifications of major aspects of myocardial ribonucleic acid metabolism as a response to noradrenaline. Action of the hormone on cytoplasmic processing of ribonucleic acid after reserpin treatment. Biochem. J. 168, 341–345 (1977)
Crass, M.F.III: Regulation of triglyceride metabolism in the isotopically prelabeled perfused heart. Fed. Proc. 36, 1995–2000 (1977)
Crass, M.F. III, Shipp, J.C., Pieper, G.M.: Effects of catecholamines on myocardial endogenous substrates and contractility. Am. J. Physiol. 228, 618–627 (1975)
Dedman, J.R., Potter, J.D., Jackson, R.L., Johnson, J.D., Means, A.R.: Physicochemical properties of rat testis Ca2+-dependent regulator protein of cyclic nucleotide phosphodiesterase. J. Biol. Chem. 252, 8415–8422 (1977)
Denton, R.M., Randle, P.J.: Hormone control of lipid concentration in rat heart and gastrocnemius. Nature (London) 208, 488 (1965)
Deguchi, T., Axelrod, J.: Supersensitivity and subsensitivity of the β-adrenergic receptor in pineal gland regulated by catecholamine transmitter. Proc. Nat. Acad. Sci. USA 70, 2411–2414 (1973)
Dobson, J.G.: Protein kinase regulation of cardiac Phosphorylase activity and contractility. Am. J. Physiol. 234, H638–H645 (1978)
Dowd, F., Schwartz, A.: The presence of cyclic AMP-stimulated protein kinase substrates and evidence for endogenous protein kinase activity in various Na+/K+-ATPase preparations from brain, heart and kidney. J. Molec. Cell. Cardiol. 7, 483–497 (1975)
Drummond, G.I., Duncan, I.: Adenyl cyclase in cardiac tissue. J. Biol. Chem. 245, 976–983 (1970)
Drummond, G.I., Severson, D.L., Duncan, L.: Adenyl cyclase. Kinetic properties and nature of fluoride and hormone stimulation. J. Biol. Chem. 246, 4166–4173 (1971)
Drummond, G.I., Dunham, J.: Adenylate cyclase in cardiac microsomal fraction. J. Molec. Cell. Cardiol. 10, 317–331 (1978)
Ehnholm, C., Kinnunen, P.K.J., Huttunen, N.K., Nikkita, E.A., Ohta, M.: Purification and characterization of lipoprotein lipase from pig myocardium. Biochem. J. 149, 649–655 (1975)
Endoh, M., Schümann, H.-J.: β- and α-adrenoceptors in the ventricular muscle of the rabbit. Naunyn-Schmiedeberg’s Arch. Pharmacol. 282, R. 18 (1974)
Endoh, M., Wagner, J., Schümann, H.-J.: Influence of temperature on the positive inotropic effects mediated by α- and β-adrenoceptors in the isolated rabbit papillary muscle. Naunyn- Schmiedeberg’s Arch. Pharmacol. 287, 61–72 (1975)
Engelhard, V.H., Plut, D.A., Storm, D.R.: Subcellular localization of adenylate cyclase in rat cardiac muscle. Biochim. Biophys. Acta 451, 48–61 (1976)
England, P.: Correlation between contraction and phosphorylation of the inhibitory subunit of troponin in perfused rat heart. FEBS letters 50, 57–60 (1975)
Entman, M.L., Levey, G.S., Epstein, S.E.: Demonstration of adenyl cyclase activity in canine cardiac sarcoplasmic reticulum. Biochem. Biophys. Res. Commun. 35, 728–740 (1969 a)
Entman, M.L., Levey, G.S., Epstein, S.E.: Mechanism of action of epinephrine and glucagon on the heart: Evidence of a cyclic 3’,5’-AMP mediated increase in cardiac sarcotubular calcium stores. Circ. Res. 25, 429–438 (1969 b)
Entman, M.L., Goldstein, M.A., Schwartz, A.: The cardiac sarcoplasmic reticulum - glycogenolytic complex, an internal beta adrenergic receptor. Life Sci. 19, 1623–1630 (1976 a)
Entman, M.L., Kaniike, K., Goldstein, M.A., Nelson, T.E., Bornet, E.P., Futch, T.W., Schwartz, A.: Association of glycogenolysis with cardiac sarcoplasmic reticulum. J. Biol. Chem. 251, 3140–3146 (1976 b)
Entman, M.L., Bornet, E.P., Garber, A.J., Schwartz, A., Levey, G.S., Lehotay, D.C., Bricker, L.A.: The cardiac sarcoplasmic reticulum-glycogenolytic complex. A possible effector site for cyclic AMP. Biochim. Biophys. Acta 499, 228–237 (1977)
Erlichman, J., Rubin, C.S., Rosen, O.M.: Physical properties of a purified cyclic adenosine 3’5’-monophosphate dependent protein kinase from bovine heart muscle. J. Biol. Chem. 248, 7607–7609 (1973)
Evans, R.J., Opie, L.H., Shipp, J.C.: Metabolism of palmitic acid in the perfused rat heart. Am. J. Physiol. 205, 766–770 (1963)
Ezrailson, E.G., van Winkle, W.B., Bornet, E.P., Entman, M.L.: A functional link between contraction and energy metabolism in cardiac and skeletal muscle. Abstr. No. 40, 7 th Internat. Congr. Pharmacol. Paris 1978
Fleckenstein, A.: Phathophysiologische Kausalfaktoren bei Myokardnekrose und Infarkt. Wiener Zeitschrift f. Innere Med. 52, 133–143 (1971)
Furchgott, R.F.: Pharmacological characteristics of adrenergic receptors. Red. Proc. 29, 1352–1361 (1970)
Gerlach, E., Zimmer, H.-G.: Alterations of myocardial adenine nucleotide metabolism. Recent Adv. in Studies on Cardiac Structure and Metabolism Vol. 7. Edit. P. Harris, R.J. Bing, and A. Fleckenstein. Baltimore: University Park Press 1976, pp. 121–130
Glass, D.B., White, J.G., Goldberg, N.D.: Rapid elevation in cyclic GMP with epinephrine- induced platelet aggregation. J. Clin. Invest. 51, 2124–2132 (1972)
Glaubiger, G., Lefkowitz, R.J.: Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem. Biophys. Res. Commun. 78, 720–725 (1977)
Glaubiger, G., Tsai, B.S., Lefkowitz, R.J., Weiss, B., Johnson, E.M., Jr.: Chronic guanethidine treatment increases cardiac β-adrenergic receptors. Nature 273, 240–242 (1978)
Glossmann, H., Struck, C.J., Konrad, C., Krawitz, M., Poppert, D., Erdmann, E., Veil, L.-B.: Adenylate cyclase regulation and β-adrenergic receptors in guinea pig myocardial tissue. In: International Boehringer Mannheim Symposium Myocardial Failure. Edit. G. Riecker, A. Weber, J. Goodwin. Berlin, Heidelberg, New York: Springer Verlag 1977, pp. 132–152
Govier, W.C.: Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents. J. Pharmacol. Exp. Ther. 159, 82–90 (1968)
Graeves, M.F.: Membrane receptor-adenylate cyclase relationships. Nature (London) 265, 681–683 (1977)
Greengard, P.: Phosphorylated proteins as physiological effectors. Sci. 199, 146–152 (1978)
Gutman, Y.: Molecular mechanisms in the modulation of catecholamine release from the adrenal medulla. Abstr. 2220 of 7 th Int. Congr. Pharmacol. Paris 1978
Haber, E., Wrenn, S.: Problems in identification of the beta-adrenergic receptor. Physiol. Rev. 56, 317–338 (1976)
Haga, T., Haga, K., Gilman, A.G.: Hydrodynamic properties of the β-adrenergic receptor and adenylate cyclase from wild type and variant S 49 lymphoma cells. J. Biol. Chem. 252, 5776–5783 (1977 a)
Haga, T., Ross, E.M., Anderson, H.J., Gilman, A.G.: Adenylate cyclase permanently uncoupled from hormone receptors in a novel variant of S49 mouse lymphoma cells. Proc. Natl. Acad. Sci. USA 74, 2016–2020 (1977b)
Hait, G., Kypson, J., Massih, R.: Amino acid incorporation into myocardium: effect of insulin, glucagon, and dibutyryl 3’,5’-AMP. Am. J. Physiol. 222, 404–408 (1972)
Hanski, E., Sevilla, N., Levitzki, A.: The allosteric inhibition by calcium of soluble and partially purified adenylate cyclase from turkey erythrocytes. Eur. J. Biochem. 76, 513–520 (1977)
Harden, T.K., Wolfe, B.B., Molinoff, P.B.: Binding of iodinated beta adrenergic antagonist to proteins derived from rat heart. Mol. Pharmacol. 12, 1–15 (1976)
Harri, M.N.E.: Metabolic and cardiovascular responses to repeated injections of alprenolol and noradrenaline in rat. Abstr. 595, 7 th Intern. Congr. Pharmacol. Paris 1978
Helmreich, E.J.M., Zenner, H.P., Pfeuffer, T., Cori, C.F.: Signal transfer from hormone receptor to adenylate cyclase. Current Topics of Cell Regul. 10, 41–87 (1976)
Henderson, J.F., Khoo, M.K.Y.: On the mechanism of feedback inhibition of purine biosynthesis de novo in Ehrlich ascites tumor cells in vitro. J. Biol. Chem. 240, 3104–3109 (1965 a)
Henderson, J.F., Khoo, M.K.Y.: Availability of 5-phosphoribosyl-l-pyrophosphate for ribonucleotide synthesis in Ehrlich ascites tumor cells in vitro. J. Biol. Chem. 240, 2358–2362 (1965 b)
Himms-Hagen, J.: Effects of catecholamines on metabolism. In: Handbook of Experimental Pharmacology Vol. 33, edited by H. Blaschko and E. Muscholl. Berlin, Heidelberg, New York: Springer Verlag 1972, pp. 363–462
Hirata, F., Axelrod, J.: Enzymatic synthesis and rapid translocation of phosphatidylcholine by two methyltransferases in erythrocyte membranes. Proc. Natl. Acad. Sci. USA 75, 2348–2352 (1978)
Ho, R.-J., Sutherland, E.W.: Formation and release of a hormone antagonist by rat adipocytes. J. Biol. Chem. 246, 6822–6827 (1971)
Ho, R.-J., Sutherland, E.W.: Action of feedback regulator on adenylate cyclase. Proc. Nat. Acad. Sci. USA 72, 1772–1777 (1975 a)
Ho, R.-J., Sutherland, E.W.: cAMP-mediated feedback regulation in target cells. Adv. Cycl. Nucl. Res. 5, 533–548 (1975b)
Ho, H.C., Wirch, E., Stevens, F.C., Wang, J.H.: Purification of a Ca2+-activable cyclic nucleotide phosphodiesterase from bovine heart by specific interaction with its Ca2+-dependent modulator protein. J. Biol. Chem. 252, 43–50 (1977)
Hofman, F., Bechtel, P., Krebs, E.G.: Concentrations of cyclic AMP-dependent protein kinase subunits in various tissues. J. Biol. Chem. 252, 1441–1447 (1977)
Hopkins, S.V.: Reduction in isoprenaline-induced cyclic AMP formation in guinea-pig heart after exposure to isoprenaline or salbutamol. Biochem. Pharmacol. 24, 1237–1239 (1975)
Hu, E.H., Venter, J.C.: Adenosine 3,,5,-monophosphate concentrations during the positive inotropic response of cat cardiac muscle to polymeric immobilized isoproterenol. Molec. Pharmacol. 14, 237–245 (1978)
Huang, K.P., Huang, F.L., Glinsmann, W.H., Robison, J.C.: Regulation of glycogen synthetase activity by two kinases. Biochem. Biophys. Res. Commun. 65, 1163–1169 (1975)
Hui, E.C., Drummond, G.I., Drummond, M.: Isolation and characterization of plasma membrane enriched fractions from guinea pig heart. Adv. Cycl. Nucl. Res. Vol. 5, edited by G.I. Drummond, P. Greengard and G.A. Robison. New York: Raven Press 1975, p. 839
Huttunen, J.K., Steinberg, D.: Activation and phosphorylation of purified adipose tissue hormone-sensitive lipase by cyclic AMP-dependent protein kinase. Biochim. Biophys. Acta 239, 411–427 (1971)
Huxtable, R., Chubb, J.: Adrenergic stimulation of taurine transport by the heart. Sci. 198, 409–411 (1977)
Imaoka, T., Imazu, M., Ishida, N., Takeda, M.: Comparison of two forms of pig heart phosphoprotein phosphatase. Biochim. Biophys. Acta 523, 109–120 (1978)
Ingebretsen, W.R., Jr., Becker, E., Friedman, W.F., Mayer, S.E.: Contractile and biochemical responses of cardiac and skeletal muscle to isoproterenol covalently linked to glass beads. Circul. Res. 40, 474–484 (1977)
Insel, P.A., Maguire, M.E., Gilman, A.G., Bourne, H.R., Coffino, P., Melmon, K.L.: Beta adrenergic receptors and adenylate cyclase: products of separate genes? Molec. Pharmacol. 12, 1062–1069 (1976)
Isaksson, O., Kallfelt, B.: Effect of adrenaline on amino acid transport in perfused rat heart. Acta Physiol. Scand. 86, 483–497 (1972)
Jacobs, K.H., Saur, W., Schultz, G.: Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J. Cycl. Nucl. Res. 2, 381–392 (1976)
Jarott, B., Picken, G.M.: Cardiac adenylate cyclase. I. Preparation and characterization of a subcellular fraction containing catecholamine-sensitive adenylate cyclase. J. Molec. Cell. Cardiol. 7, 685–697 (1975)
Jones, L.R., Besch, H.R., Jr., Fleming, J.W., McConnaughey, M.M., Watanabe, A.M.: Comparative biochemical analysis of purified membrane vesicles from cardiac sarcolemma and sarcoplasmic reticulum. Fed. Proc. 37, 517 (1978)
Jungmann, R.A., Russell, D.H.: Minireview. Cyclic AMP, cyclic AMP-dependent protein kinase and the regulation of gene expression. Life Sci. 20, 1787–1798 (1977)
Kakiuchi, S., Yamazaki, R., Nakajima, H.: Properties of a heat-stable phosphodiesterase activating factor isolated from brain extract. Studies on cyclic 3’,5’-nucleotide phosphodiesterase II. Proc. Jpn. Acad. 46, 587–592 (1970)
Kakiuchi, S., Yamazaki, R., Teshima, Y., Uenishi, K., Miyamato, E.: Multiple cyclic nucleotide phosphodiesterase activities of rat tissues and occurrance of a calcium-plus magnesium-ion-dependent phosphodiesterase and its protein activator. Biochem. J. 146, 109–120 (1975)
Kako, K.: Biochemical changes of the rat myocardium induced by isoproterenol. Can. J. Physiol. Pharmacol. 43, 541–549 (1965)
Kallfelt, B.J., Hjalmarson, A.C., Isaksson, O.G.: In vitro effects on protein synthesis in perfused rat heart. J. Molec. Cell. Cardiol. 8, 787–802 (1976)
Kallfelt, B.J., Waldenstrom, A.P., Hjalmarson, A.C.: Effects of adrenaline in vivo ion protein synthesis and sensitivity to ischemia of the perfused rat heart. J. Molec. Cell. Cardiol. 9, 383–398 (1977)
Katz, A.M., Repke, D.I.: Calcium-membrane interaction in the myocardium: Effects of ouabain, epinephrine and 3’,5’-cyclic adenosine monophosphate. Am. J. Cardiol. 31, 193–201 (1973)
Katz, A.M., Tada, M., Repke, D.I., Kirchberger, M.A., Iotio, J.M.: Adenylate cyclase: its probable localization in the heart’s sarcoplasmic reticulum as well as sarcolemma. J. Molec. Cell. Cardiol. 6, 75–78 (1974)
Kaumann, A.J., Birnbaumer, L.: Studies on receptor-mediated activation of adenylyl cyclases. IV. Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase: Stereospecificity for ligands and determination of apparent affinity constants for β-blockers. J. Biol. Chem. 25, 7874–7885 (1974)
Kaumann, A. J., Birnbaumer, L.: Desensitization of kitten atria to chronotropic, inotropic and adenylyl cyclase stimulating effects of (–)isoprenaline. Naunyn-Schmiedeberg’s Arch. Pharmacol. 293, 199–202 (1976)
Kaumann, A.J., Bojar, H.: Relationship between the cellular number of occupied β-adrenoceptors and inotropic effects of catecholamines in hearts of reserpine-pretreated kittens. Abstract 2780, 7 th Internat. Congr. Pharmacol. Paris 1978
Kebabian, J.W., Zatz, M., Romero, J.A., Axelrod, J.: Rapid changes in rat pineal β-adrenergic receptor: alteration in l-[3H]alprenolol binding and adenylate cyclase. Proc. Natl. Acad. Sci. USA 72, 3735–3739 (1975)
Keely, S.L., Corbin, J.D., Park, C.R.: Regulation of adenosine 3’,5’-monophosphate-dependent protein kinase. Regulation of the heart enzyme by epinephrine, glucagon, insulin, and 1 -methyl-3-isobutylxanthine. J. Biol. Chem. 250, 4832–4840 (1975)
Keely, S.L., Corbin, J.D., Lincoln, T.: Alpha adrenergic involvement in heart metabolism: effects on adenosine cyclic 3’,5’-monophosphate, adenosine cyclic 3’,5’-monophosphate-dependent protein kinase, guanosine cyclic 3’,5’-monophosphate, and glucose transport. Molec. Pharmacol. 13, 965–975 (1977)
Kleitke, B., Sydow, H., Wollenberger, A.: Evidence for mitochondrial membrane-bound cAMP-dependent protein kinase (cAMP). Abstract 1327 12 th FEBS Meeting Dresden 1978
Kleitke, B., Wollenberger, A.: Accelerated RNA and protein synthesis in mitochondria isolated from ischemic myocardium. J. Molec. Cell. Cardiol. 10, 827–845 (1978)
Krause, E.-G., Wollenberger, A.: Cyclic nucleotides and heart. In: Cyclic 3’,5’-Nucleotides: Mechanism of Action. Edit. H. Cramer and J. Schultz. London, New York, Toronto: John Wiley & Sons 1977, pp. 229–250
Krause, E.-G., Will, H., Pelouch, V., Wollenberger, A.: Cyclic AMP-dependent protein kinase activity in a cell membrane enriched fraction of pig myocardium. Adv. Cycl. Nucl. Res. 5, 473–490 (1975)
Kreisberg, R.A.: Effect of epinephrine on myocardial triglyceride and free fatty acid utilization. Amer. J. Physiol. 210, 385–389 (1966)
Krawietz, W., Poppert, D., Ermann, E., Glossmann, H., Struck, C.J., Konrad, C.: β-Adrenergic receptors in guinea pig myocardial tissue. Naunyn-Schmiedeberg’s Arch. Pharmacol. 295, 215–224 (1976)
Kunos, G., Yong, M.S., Nickerson, M: Transformation of adrenergic receptors in the myocardium. Nature, New Biol. 241, 119–120 (1973)
Kunos, G., Vermes-Kunos, I., Nickerson, M.: Effects of thyroid state on adrenoceptor properties. Nature 250, 779–781 (1974)
Kunos, G., Szentivanyi, M.: Evidence favouring the existence of a single adrenergic receptor Nature (Lond.) 217, 1077–1078 (1968)
Kunos, G., Mucci, L., Jaeger, V.: Interconversion of myocardial adrenoceptors: its relationship to adenylate cyclase activation. Sci. 19, 1597–1602 (1976)
Kunos, G., Nickerson, M.: Temperature-induced interconversion of α- and β-adrenoceptors in the frog heart. J. Physiol. 256, 23–40 (1976)
Kunos, G.: Thyroid hormone-dependent interconversion of myocardial α- and β-receptors in the heart. Brit. J. Pharmacol. 59, 177–189 (1977)
Kunos, G.: Adrenoceptors. Ann. Rev. Pharmacol. Toxicol. 18, 291–311 (1978)
Kuo, J.F.: Changes in relative levels of guanosine-3’,5’-monophosphate-dependent and adenosine-3’,5’-monophosphate dependent protein kinases in lung, heart, and brain of developing guinea pigs. Proc. Natl. Acad. Sci. 72, 2256–2259 (1975)
Kuo, J.F., Greengard, P.: Cyclic nucleotide-dependent protein kinases Widespread occurance of adenosine 3’,5’-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom. Proc. Natl. Acad. Sci. USA 64, 1349–1355 (1969)
Kuo, J.F., Kruger, B.K., Sanes, J.A., Greengard, P.: Cyclic nucleotide-dependent protein kinase from various bovine tissues. Biochim. Biophys. Acta 212, 79–91 (1970)
Laks, M.M., Morady, F.: Norepinephrine - The myocardial hypertrophy hormone? Amer. Heart J. 91, 674 (1976)
Laks, M.M.: Norepinephrine - The producer of myocardial cellular hypertrophy and/or necrosis and/or fibrosis. Amer. Heart J. 94, 394–395 (1977)
Lands, A.M., Arnold, A., McAuliff, J.P., Luduena, F.P., Brown, T.G., Jr.: Differentiation of receptor system activated by sympathomimetic amines. Nature (Lond.) 214, 597–598 (1967)
Lech, J.J., Jesmol, G.J., Calvert, D.N.: Effect of drugs and hormones on lipolysis in heart. Fed. Proc. 36, 2000–2008 (1977)
Lefkowitz, R.J.: Stimulation of catecholamine-sensitive adenylate cyclase by 5’-guanylyl-imidodiphosphate. J. Biol. Chem. 249, 6119–6124 (1974)
Lefkowitz, R.J.: Catecholamine stimulated myocardial adenylate cyclase: Effects of nucleotides. J. Molec. Cell. Cardiol. 7, 237–248 (1975 a)
Lefkowitz, R.J.: Guanosine triphosphate binding sites in solubilized myocardium. J. Biol. Chem. 250, 1006–1011 (1975 b)
Lefkowitz, R.J.: Catecholamine stimulated myocardial adenylate cyclase: Effects of phospholipase digestion and the role of membrane lipids. J. Molec. Cell. Cardiol. 7, 27–37 (1975 c)
Lefkowitz, R.J.: Heterogeneity of adenylate cyclase-coupled β-adrenergic receptors. Biochem. Pharmacol. 24, 583–590 (1975 d)
Lefkowitz, R.J., Mullikin, D., Caron, M.G.: Regulation of β-adrenergic receptors by guanyl- 5’-yl imidodiphosphate and other purine nucleotides. J. Biol. Chem. 251, 4686–4692 (1976)
Lefkowitz, R.J., Hamp, M.: Comparison of specificity of agonist and antagonist radioligand binding to β-adrenergic receptors. Nature (London) 268, 453–454 (1977)
Lefkowitz, R.J., Williams, L.T.: Catecholamine binding to the β-adrenergic receptor. Proc. Natl. Acad. Sci. USA 74, 515–519 (1977)
Lehotay, D.C., Levey, G.S., Vesely, D.L., Bornet, E.O., Ray, M.V., Entman, M.L., Schwartz, A.: The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart. J. Cyclic Nucl. Res. 3, 55–65 (1977a)
Lehotay, D.C., Lo, H.K., Levey, G.S.: Activation of adenylate cyclase:requirement for phospholipids. In: Cyclic 3’, 5’-Nucleotides: Mechanism of Action. Edited by H. Cramer and J. Schultz, London, New York, Sydney, Toronto: John Wiley & Sons, 1977b, pp. 1–13
Levey, G.S.: Restoration of glucagon responsiveness of solubilized myocardial adenyl cyclase by phosphotidylserine. Biochem. Biophys. Res. Commun. 43, 108–113 (1971a)
Levey, G.S.: Restoration of norepinephrine responsiveness of solubilized myocardial adenylate cyclase by phosphatidylinositol. J. Biol. Chem. 246, 7405–7410 (1971b)
Levey, G.S.: Solubilization of myocardial adenyl cyclase: Loss of hormone responsiveness and activation by phospholipids. Ann. N.Y. Acad. Sci. 185, 449–457 (1971c)
Levey, G.S., Klein, I.: Solubilized myocardial adenyl cyclase: Restoration of histamine responsiveness by phosphatidylserine. J. Clin. Invest. 51, 1578–1582 (1972)
Levey, G.S.: The role of phospholipids in hormone activation of adenylate cyclase. Recent Prog. Horm. Res. 29, 361 (1973)
Levey, G.S., Lehotay, D.C., Canterbury, J.M., Bricker, L.A., Meltz, G.J.: Isolation of a unique peptide inhibitor of hormone-responsive adenylate cyclase. J. Biol. Chem. 250, 5730–5733 (1975)
Levitzki, A.: The role of GTP in the activation of adenylate cyclase. Biochem. Biophys. Res. Commun. 74, 1154–1159 (1977)
Li, H.-C., Hsiao, K.-J., Chan, W.W.S.: Purification and properties of phosphoprotein phosphatases with different substrate and divalent cation specificities from canine heart. Eur. J. Biochem. 24, 215–225 (1978)
Limbird, L.E., Lefkowitz, R.J.: Resolution of β-adrenergic receptor binding and adenylate cyclase activity by gel exclusion chromatography. J. Biol. Chem. 252, 799–802 (1977)
Lin, Y.M., Liu, Y.P., Cheung, W.Y.: Cyclic 3’,5’-nucleotide phosphodiesterase. Purification, characterization and active form of the protein activator from bovine brain. J. Biol. Chem. 249, 4943–4954 (1974)
Lincoln, T., Corbin, J.D.: Purified cyclic GMP-dependent protein kinase catalyzes the phosphorylation of cardiac troponin inhibitory subunit (TN-I). J. Biol. Chem. 253, 337–339 (1978 a)
Lincoln, T.M., Corbind, J.D.: On the role of the cAMP and cGMP-dependent protein kinases in cell function. J. Cycl. Nucl. Res. 4, 3–14 (1978 b)
Loakpradit, T., Lockwood, R.: Differentiation of metabolic adrenoreceptors. Brit. J. Pharmacol. 59, 135–140 (1977)
Lynch, T.J., Tallant, E.A., Cheung, W.Y.: Ca2+-dependent formation of brain adenylate cyclase-protein activator complex. Biochem. Biophys. Res. Commun. 68, 616–624 (1976)
Maguire, M.E., Sturgill, T.W., Gilman, A.G.: Frustration and adenylate cyclase. Metab. 24, 287–299 (1975)
Maguire, M.E., van Arsdale, P.M., Gilman, A.G.: An agonist-specific effect of guanine nu-cleotides on binding to the beta adrenergic receptor. Molec. Pharmacol. 12, 335–339 (1976)
Maguire, M.E., Ross, E.M., Gilman, A.G.: β-Adrenergic receptor: Ligand binding properties and the interaction with adenylyl cyclase. Adv. Cycl. Nucl. Res. Vol. 8, Ed. P. Greengard and G.A. Robison. New York: Raven Press 1977, pp. 1–75
Malik, A.B., Geha, A.S.: Role of adrenergic mechanism in the development of cardiac hypertrophy. Proc. Soc. Exptl. Biol. Med. 150, 796–802 (1975)
Malov, S.: Effect of sympathomimetic drugs on protein synthesis in rat heart. J. Pharmacol. Exptl. Ther. 187, 482–494 (1973)
Malov, S.: Effect of sympathomimetic amines and monoamino oxidase inhibitors on protein synthesis in rat heart. Biochem. Pharmacol. 25, 1645–1651 (1976)
Masters, T.N., Glaviano, V.V.: Effect of norepinephrine and propranolol on myocardial subcellular distribution of triglycerides and free fatty acids. J. Pharmacol. Exp. Ther. 182, 246–255 (1972)
Matheny, J.L., Ahlquist, R.P.: Adrenoceptor alteration by temperature in iris dilator muscle of rabbit. Arch. Int. Pharmacodyn. Ther. 209, 197–203 (1974)
Matheny, J.L., Ahlquist, R.P.: Metabolic inhibition and adrenoceptor interconversion. Arch. Int. Pharmacodyn. Ther. 218, 4–10 (1975)
Mathur, P.P., Mokler, C.M.: Subcellular distribution and incorporation of palmitate — 14C into myocardial lipids: Role of endogenous and exogenous catecholamines. J. Molec. Cell. Cardiol. 7, 17–26 (1975)
Mayer, S.E.: Adrenergic receptor for metabolic responses in the heart. Fed. Proc. 29, 1367–1372 (1970)
Mayer, S.E.: Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver. J. Pharmacol. Exp. Ther. 181, 116–125 (1972)
Mayer, S.E.: Effect of catecholamines on cardiac metabolism. Circul. Res., Suppl. III 34–35, 129–137 (1974)
Merouze, P., Gaudemer, Y., Gautheron, D.: Effect of catecholamines on rat myocardial metabolism. I. Influence of catecholamines on energy-rich nucleotides and phosphorylated fraction contents. Biochem. 57, 797–802 (1975 a)
Merouze, P., Gaudemer, Y., Gautheron, D.: Effect of catecholamines on rat myocardial metabolism. II. Influence of catecholamines on 32P-incorporation into rat myocardial adenylic nucleotides and their turnover. Biochem. 57, 803–810 (1975b)
Mickey, J., Tate, R., Lefkowitz, R.J.: Subsensitivity of adenylate cyclase and decreased β-adrenergic receptor binding after chronic exposure to (—)-isoproterenol in vitro. J. Biol. Chem. 250, 5727–5729 (1975)
Misselwitz, H.-J., Will, H., Schulze, W., Will-Shahab, L., Wollenberger, A.: Mass isolation of cell surface membrane fragments from pigeon heart. Biochim Biophys. Acta 553, 197–212 (1979)
Miura, Y., Inui, J., Imamura, H.: Alpha-adrenoceptor-mediated restoration of calcium-dependent potential in the partially depolarized rabbit papillary muscle. Naunyn Schmiedeberg’s Arch. Pharmacol. 301, 201–205 (1978)
Moir, A.J.G., Wilkinson, J.M., Perry, S.V.: The phosphorylation sites of troponin 1 from skeletal muscle of the rabbit. Febs letters 42, 253–256 (1974)
Mukherjee, C., Lefkowitz, R.J.: Desensitization of β-adrenergic receptors by β-adrenergic agonists in a cell-free system: resensitization by guanosine 5’-(β, γ-imino)triphosphate and other purine nucleotides. Proc. Natl. Acad. Sci. 73, 1494–1498 (1976)
Mukherjee, C., Caron, M.G., Lefkowitz, R.J.: Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of β-adrenergic receptor binding sites. Proc. Nat. Acad. Sci. USA 72, 1945–1949 (1975)
Mukherjee, C., Caron, M.G., Lefkowitz, R.J.: Regulation of adenylate cyclase coupled β-ad-renergic receptors by β-adrenergic catecholamines. Endocrinol. 99, 347–357 (1976)
Murad, F., Chi, Y.-M., Rail, T.W., Sutherland, E.W.: Adenyl cyclase. J. Biol. Chem. 237, 1233–1238 (1962)
Murad, F.: Beta blockade of epinephrine-induced cyclic AMP formation in heart, liver, fat and trachea. Biochim. Biophys. Acta 304, 181 (1973)
Nair, K.G.: Catecholamine-induced hypertrophy. Amer. Heart J. 94, 393–394 (1977)
Namm, D.H., Mayer, S.E.: Effects of epinephrine on cardiac cyclic 3’,5’-AMP, phosphorylase kinase and phosphorylase. Molec. Pharmacol. 4, 61–69 (1968)
Narayanan, N., Sulakhe, P.V.: Characteristics of guanylyl nucleotide binding sites in guinea pig heart sarcolemma. Int. J. Biochem. 8, 591–599 (1977)
Neely, J.R., Denton, R.M., England, P.S., Randle, P.J.: Effect of increased heart on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem. J. 128, 147–159 (1972)
Nesher, R., Robinson, W.F., Gibb, L., Bishop, S.P., Kruger, F.A.: RNA polymerase in isolated heart nuclei and their responses to cyclic nucleotides. J. Molec. Cell. Cardiol. 2, 579–593 (1977)
Nickerson, M., Kunos, G.: Discussion of evidence regarding induced changes in adrenoceptors. Fed. Proc. 36, 2580–2583 (1977)
Nimmo, H.G., Cohen, P.: Hormonal control of protein phosphorylation. Adv. Cycl. Nucl. Res. 8, 145–247 (1977)
Olson, R.E., Hoeschen, R.J.: Utilization of endogenous lipid by the isolated perfused rat heart. Biochem. J. 103, 796–801 (1967)
Östmann-Smith, I.: Prevention of exercise-induced cardiac hypertrophy in rats by chemical sympathectomy (guanethidine treatment). Neurosci. 1, 497–507 (1976)
Palmer, G.C., Spurgeon, H.A., Priola, D.V.: Involvement of adenylate cyclase in mechanisms of denervation supersensitivity following surgical denervation of the dog heart. J. Cyclic Nucl. Res. 1, 89–95 (1975)
Perkins, J.P.: Adenyl cyclase. Adv. Cycl. Nucl. Res. Vol. 3, 1–64 (1973)
Perkins, J.P., Moore, M.M.: Characterization of the adrenergic receptors mediating a rise in cyclic 3’,5’-adenosine monophosphate in rat cerebral cortex. J. Pharmacol. Exp. Ther. 185, 371–378 (1973)
Peters, K.A., Demaille, J.G., Fischer, E.H.: Adenosine 3’,5’-monophosphate dependent protein kinase from bovine heart. Characterization of the catalytic subunit. Biochem. 16, 5691–5697 (1977)
Petrack, B., Czernik, A.J.: Inhibition of isoproterenol activation of adenylate cyclase by metroprolol, oxprenolol, and the para isomer of oxprenolol. Molec. Pharmacol. 12, 203–207 (1976)
Pfeuffer, T.: GTP-binding proteins in membranes and the control of adenylate cyclase activity. J. Biol. Chem. 252, 7224–7234 (1977)
Pfeuffer, T., Helmreich, E.J.H.: Activation of pigeon erythrocyte membrane adenylate cyclase by guanylnucleotide analogues and separation of a nucleotide binding protein. J. Biol. Chem. 250, 867–876 (1975)
Pfeuffer, T., Bakardjeva, A., Helmreich, E.J.M.: Signal transfer from β-receptors to adenylate cyclase. Abstr. 2222, 7 th Internat. Congr. Pharmacol. Paris 1978
Pik, K., Wollemann, M.: Catecholamine hypersensitivity of adenylate cyclase after chemical denervation in rat heart. Biochem. Pharmacol. 26, 1448–1449 (1977)
Plauchithiu, M.G., Rocsin, M., Simon, Z.: Stereochemic model for the function of adrenergic alpha receptors coupled to transport systems. Abstr. 2426, 7 th Internat. Congr. Pharmacol. Paris 1978
Raine, A.E.G., Chubb, I.W.: Long term β-adrenergic blockade reduces tyrosine hydroxylase and dopamine β-hydroxylase activities in sympathetic ganglia. Nature 267, 265–267 (1977)
Rangel-Aldao, R., Rosen, O.M.: Effect of cAMP and ATP on the reassociation of phosphorylated and nonphosphorylated subunits of the cAMP-dependent protein kinase from bovine cardiac muscle. J. Biol. Chem. 252, 7140–7145 (1977)
Rasmussen, H.: Cell communication, calcium ion and cyclic adenosine monophosphate. Sci. 173, 404–412 (1970)
Rasmussen, H., Tenenhouse, A.: Cyclic adenosine monophosphate, Ca and membranes. Proc. Natl. Acad. Sei. USA 59, 1364–1370 (1968)
Rasmussen, H., Jensen, P., Labe, W., Friedman, N., Goodman, B.D.: Cyclic nucleotides and cellular Ca2+ metabolism. Adv. Cycl. Nucl. Res. 5, 375–394 (1975)
Ray, K.P., England, P.J.: Phosphorylation of the inhibitory subunit of troponin and its effect on the calcium dependence of cardiac myofibril adenosine triphosphatase. Febs letters 70, 11–16 (1976)
Reddy, Y.S.: Phosphorylation of cardiac regulatory proteins by cyclic AMP-dependent protein kinase. Am. J. Physiol. 231, 1330–1336 (1976)
Reddy, Y.S., Ballard, D., Giri, N.Y., Schwartz, A.: Phosphorylation of cardiac native tropomyosin and troponin. Inhibitory effect of actomyosin and possible presence of endogenous myofibrillar-located, cyclic AMP-dependent protein kinase. J. Molec. Cell. Cardiol. 5, 461–471 (1973)
Rethy, A., Tomasi, Y., Trevisani, A., Barnatei, E.: The role of phosphatidylserine in the hormonal control of adenylate cyclase of rat liver plasma membranes. Biochim. Biophys. Acta 200, 58–59 (1972)
Reuter, H., Scholz, H.: The regulation of the Ca conductance of cardiac muscle by adrenaline. J. Physiol. (Lond.) 264, 49–62 (1976)
Robison, G.A., Butcher, R.W., Sutherland, E.W.: Adenyl cyclase as an adrenergic receptor. Ann. New York Acad. Sci. 139, 703–723 (1967)
Robison, G. A., Arnold, A., Hartman, R.C.: Divergent effects of epinephrine and prostaglandin E1 on the level of cyclic AMP in human blood platelets. Pharmacol. Res. Commun. 1, 325–332 (1969)
Robison, G.A., Butcher, R.W., Sutherland, E.W.: The catecholamines. In: Cyclic AMP. Edit. G.A. Robison, R.W. Butcher and E.W. Sutherland. New York: Academic Press 1971, pp. 146–231
Rodbell, M., Lin, M.C., Salomon, Y., Londos, C., Harwood, J.P., Martin, M.R., Rendell, M., Berman, M.: Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multisile transition states. Adv. Cycl. Nucl. Res. 5, 3–29 (1975)
Ross, E.M., Gilman, A.G.: Reconstitution of catecholamine-sensitive adenylate cyclase activity: Interaction of solubilized components with receptor-replete membranes. Proc. Natl. Acad. Sci. USA 74, 3715–3719 (1977 a)
Saitoh, Y., Morita, S., Irie, Y., Kohri, H.: Evaluation of a new beta-adrenergic blocking agent, casteolol, based on metabolic responses in rats - II. Blockade by casteolol of the epinephrine and isoproterenol-induced increases of tissue and blood cyclic AMP in vivo. Biochem. Pharmacol. 25, 1843–1849 (1976)
Sato, K.: Stimulation of pentose cycle in the eccrine sweat gland by adrenergic drugs. Amer. J. Physiol. 224, 1149–1154 (1973)
Scheur, J., Olsen, R.E.: Metabolism of exogenous triglycerides by the isolated perfused rat heart. Am. J. Physiol. 212, 301–307 (1967)
Schlender, K.K., Wei, S.H., Villar-Palasi, C.: UDP-glucose: glycogen α-4-glucosyl-transferase I kinase activity of purified muscle protein kinase. Biochim. Biophys. Acta 191, 272–278 (1969)
Schramm, M., Orly, J., Eimerl, S., Korner, M.: Coupling of hormone receptors to adenylate cyclase of different cells by cell fusion. Nature (London) 268, 310–313 (1977)
Schultz, G., Hardman, J.G., Schultz, K., David, J.W., Sutherland, E.W.: A new enzymatic assay for guanosine 3’:5’-cyclic monophosphate and its application to the ductus deferens of the rat. Proc. Nat. Acad. Sci. USA 70, 1721–1725 (1973)
Schulze, W., Krause, E.-G., Wollenberger, A.: Cytochemical demonstration and localization of adenylate cyclase in skeletal and cardiac muscle. Adv. Cycl. Nucl. Res. Vol. 1, edited by P. Greengard, G.A. Robison, R. Paoletti. New York: Raven Press 1972, pp. 249–260
Schulze, W., Hinterberger, U., Wollenberger, A., Krause, E.-G., Janiszewski, E.: Problems of the cytochemical demonstration of adenylate cyclase. Acta histochem. Cytochem. 10, 371–378 (1977)
Schümann, H.J., Endoh, M.: α-adrenoceptors in the ventricular myocardium: Clonidine, Naphazolin and Methoxamine as partial α-agonists exerting a competitive dualism in action to phenylephrine. Europ. J. Pharmacol. 36, 413–421 (1976)
Schümann, H.J., Wagner, J., Reinhardt, D.: Sensitivity changes of adrenergic β-receptors induced by alterations of the metabolic state in isolated organs. Naunyn Schmiedeberg’s Arch. Pharmacol. 275, 105–113 (1972)
Schümann, H.J., Endoh, M., Wagner, J.: Positive inotropic effects of phenylephrine in the isolated rabbit papillary muscle mediated both by α- and β-adrenoceptors. Naunyn Schmiede- berg’s Arch. Pharmacol. 284, 133–148 (1974)
Schwartz, A., Entman, M.L., Kaniike, K., Lane, L.K., van Winkle, W.B., Bornet, E.P.: The rate of calcium uptake into sarcoplasmic reticulum of cardiac muscle and skeletal muscle: Effect of cyclic AMP-dependent protein kinase and phorphorylase b kinase. Biochim. Biophys. Acta 426, 57–72 (1976)
Schwartz, A., Entman, M.L., Ezrailson, E.G., Lehotay, D.C., Levey, G.: Possible cyclic nucleotide regulation of calcium mediating myocardial contraction. Sci. 195, 982–990 (1977)
Schwarzmeier, J.D., Gilman, A.G.: Reconstitution of catecholamine-sensitive adenylate cyclase activity: interaction of components following cell-cell and membrane-cell fusion. J. Cyclic Nucl. Res. 3, 227–238 (1977)
Shipp, J.C., Opie, L.H., Challower, D.: Fatty acid and glucose metabolism in the perfused heart. Nature (London) 189, 1018–1019 (1961)
Smoake, J.A., Song, S.-Y., Cheung, W.Y.: Cyclic 3’,5’-nucleotide phosphodiesterase. Distribution and developmental changes of the enzyme and its protein activator in mammalian tissue and cells. Biochim. Biophys. Acta 341, 402–411 (1974)
Sporn, J.R., Harden, T.K., Wolfe, B.B., Molinoff, P.B.: β-adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex. Sci. 194, 624–626 (1976)
Stein, O., Stein, Y.: Lipid synthesis, intracellular transport and storage. III. Electron microscopic radioautographic study of the rat heart perfused with tritiated oleic acid. J. Cell. Biol. 36, 163–177 (1968)
Steinberg, D., Huttunen, J.K.: The role of cyclic AMP in activation of hormone-sensitive lipase of adipose tissue. In: Adv. Cycl. Nucl. Res. 1, 47–62 (1972)
St. Louis, P.J., Sulakhe, P.F.: Adenylate cyclase, guanylate cyclase and cyclic nucleotide phosphodiesterase of guinea-pig cardiac sarcolemma. Biochem. J. 158, 535–541 (1976)
Strittmatter, W.J., Davis, N., Lefkowitz, R.J.: α-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium efflux. J. Biol. Chem. 252, 5472–5478 (1977)
Sulakhe, P.V., Dhalla, N.S.: Adenylate cyclase of heart sarco tubular membranes. Biochim. Biophys. Acta 293, 379–394 (1973)
Sulakhe, P.V., Drummond, G.I.: Protein kinase-catalyzed phosphorylation of muscle sarcolemma. Arch. Biochem. Biophys. 161, 448–455 (1974)
Sulakhe, P.V., Leung, N.L.K., St. Louis, P.J.: Stimulation of calcium accumulation in cardiac sarcolemma by protein kinase. Can. J. Biochem. 54, 438–445 (1976)
Sutherland, E.W., Rail, T.W.: The relation of adenosine 3’,5’-phosphate and Phosphorylase to the actions of catecholamines and hormones. Pharmacol. Rev. 12, 265–299 (1960)
Sutherland, E.W., Oye, I., Butcher, R.W.: The action of epinephrine and the role of the adenyl cyclase system in hormone action. Recent Progr. Hormone Res. 21, 623–646 (1965)
Sutherland, E.W., Robison, G.A.: The role of cyclic 3’,5’-AMP in responses to catecholamines and other hormones. Pharmacol. Rev. 18, 145–161 (1966)
Sutherland, E.W., Robison, G.A., Butcher, R.W.: Some aspects of the biological role of adenosine 3’,5’-monophosphate (cyclic AMP). Circul. 37, 279–306 (1968)
Szmigielski, A., Guidotti, A., Costa, E.: Endogenous protein kinase inhibitors. J. Biol. Chem. 252, 3848–3853 (1977)
Tada, M., Kirchberger, M.A., Katz, A.M.: Phosphorylation of a 22000-dalton component of the cardiac sarcoplasmic reticulum by adnosine 3’,5’-monophosphate-dependent protein kinase. J. Biol. Chem. 250, 2640–2647 (1975)
Tada, M., Kirchberger, M.A., Iorio, J.M., Katz, A.M.: Control of cardiac sarcolemmal adenylate cyclase and sodium, potassium-activated adenosine triphosphatase activities. Circul. Res. 36, 8–17 (1976)
Teo, T.S., Wang, H.J.: Mechanism of activation of a cyclic adenosine 3’,5’-monophosphate phosphodiesterase from bovine heart by calcium ions. J. Biol. Chem. 248, 5950–5955 (1973 a)
Teo, T.S., Wang, T.H., Wang, J.H.: Purification and properties of the protein activator of bovine heart cyclic adenosine 3’,5’-monophosphate phosphodiesterase. J. Biol. Chem. 248, 588–595 (1973 b)
Thoenen, H., Tranzer, J.P.: Chemical sympathectomy by selective destruction of adrenergic nerve endings by 6-hydroxydopamine. Arch. Exp. Path. Pharmak. 261, 271–288 (1968)
Tsien, R.W.: Cyclic AMP and contractile activity in heart. Adv. Cycl. Nucl. Res. 8, 364–420 (1978)
Turtle, J.R., Kipnis, D.M.: An adrenergic receptor mechanism for the control of cyclic 3’,5’- adenosine monophosphate synthesis in tissues. Biochem. Biophys. Res. Commun. 28, 797 (1967)
Vauquelin, G., Geynet, P., Hanoune, J., Strosberg, D.: Isolation of adenylate cyclase-free, β- adrenergic receptor from turkey erythrocyte membranes by affinity chromatography. Proc. Natl. Acad. Sci. USA 74, 3710–3714 (1977)
Velema, J., Noordam, P.C., Zaagsma, J.: Isolation and cAMP-dependent phosphorylation of plasma membrane and sarcoplasmic reticulum from rat heart muscle. Abstr. 2472, 7 th Internat. Congr. Pharmacol., Paris 1978
Venter, J.C., Ghai, G.: Characterization of caninc cardiac, right and left ventricular β-adrenergic receptors with [1251] iodohydroxybenzylpindolol. The Pharmacologist 19, 244 (1977)
Venter, J.C., Kaplan, N.O.: A partial purification of the β-adrenergic receptor adenylate cyclase complex by affinity chromatography to glass bead-immobilized isoproterenol. Methods of Enzymology, Vol. XXXVIII, Part C, edited by J.G. Hardman and B.W. O’Malley. New York, San Francisco, London: Academic Press 1974 a, pp. 180–186
Venter, J.C., Kaplan, N.O.: Technical comments: Stability of catecholamines immobilized on glass beads. Sci. 185, 459–460 (1974b)
Venter, J.C., Dixon, J.E., Maroko, P.R., Kaplan, N.O.: Biologically active catecholamines covalently bound to glass beads. Proc. Nat. Acad. Sci. USA 69, 1141–1145 (1972)
Wagner, J., Endoh, M., Reinhardt, D.: Stimulation by phenylephrine of adrenergic alpha- and beta-receptors in the isolated perfused rabbit heart. Naunyn-Schmiedeberg’s Arch. Pharmacol. 282, 307–310 (1974a)
Wagner, J., Reinhardt, D.: Characterization of the adrenoceptors mediating the positive ino- and chronotropic effect of phenylephrine on isolated atria from guinea pigs and rabbits by means of adrenolytic drugs. Naunyn-Schmiedeberg’s Arch. Pharmacol. 282, 295–306 (1974b)
Wagner, J., Brodde, O.-E.: On the presence and distribution of α-adrenoceptors in the heart of various mammalian species. Naunyn-Schmiedeberg’s Arch. Pharmacol. 302, 239–254 (1978)
Waisman, D., Stevens, F.C., Wang, J.H.: The distribution of the Ca2+-dependent protein activator of cyclic nucleotide phosphodiesterase in vertebrates. Biochem. Biophys. Res. Commun. 65, 975–982 (1975)
Walsh, D.A., Ashby, C.D.: Protein kinases: Aspects of their regulation and diversity. Rec. Prog. Hormone Res. 29, 329–359 (1973)
Walsh, D.A., Ashby, C.D., Gonzales, C., Calkins, D., Fisher, E.H., Krebs, E.G.: Purification and characterization of a protein inhibitor of cyclic AMP-dependent protein kinase. J. Biol. Chem. 246, 1977–1985 (1971)
Wang, J.H., Teo, T.S., Ho, C.H., Stevens, F.C.: Bovine heart protein activator of cyclic nucleotide phosphodiesterase. Adv. Cycl. Nucl. Res. 5, 179–194 (1975)
Watanabe, A.M., Besch, H.R., Jr.: Myocardial adenylate cyclase: Studies on the relationship of activity to purity of sarcolemmal preparation. J. Molec. Cell. Cardiol. 7, 563–575 (1975)
Watanabe, A.M., Hathaway, D.R., Besch, H.R., Jr., Farmer, B.B., Harris, R.A.: α-Adrenergic reduction of cyclic adenosine monophosphate concentrations in rat myocardium. Circul. Res. 40, 596–602 (1977)
Weiss, B., Hait, W.N.: Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents. Ann. Rev. Pharmacol. Toxicol. 17, 441–471 (1977)
Will, H., Levchenko, T.S., Levitsky, D.O., Smirnov, V.N., Wollenberger, A.: Partial characterization of protein kinase-catalyzed phosphorylation of low-molecular weight proteins in purified preparations of pigeon heart sarcolemma and sarcoplasmic reticulum. Biochim. Biophys. Acta 543, 175–193 (1978)
Williams, L.T., Lefkowitz, R.J., Watanabe, A.M., Hathaway, D.R., Besch, H.R., Jr.: Thyroid hormone regulation of β-adrenergic receptor number. J. Biol. Chem. 252, 2787–2789 (1977 a)
Williams, L.T., Lefkowitz, R.J.: Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the β-adrenergic receptor. J. Biol. Chem. 252, 7207–7213 (1977 b)
Williamson, J.R.: Metabolic effects of epinephrine in the isolated perfused rat heart. I. Dissociation of the glycogenolytic from the metabolic stimulatory effect. J. Biol. Chem. 239, 2721–2729 (1964)
Will-Shahab, L., Bartel, S., Wollenberger, A., Küttner, I.: Beta-adrenergic receptor binding sites, activity of adenylate cyclase and phosphodiesterase in heart membranes of rats differing in thyroid state. Abstr. 2932, 7 th Internat. Congr. Pharmacol., Paris 1978
Wolfe, B.B., Harden, T.K., Molinoff, P.B.: In vitro study of β-adrenergic receptors. Ann. Rev. Pharmacol. Toxicol. 17, 575–604 (1977)
Wolff, D.J., Brostrom, C.O.: Calcium binding phosphoprotein from pig brain: identification as a Ca2+ dependent regulator of rat brain nucleotide phosphodiesterase. Arch. Biochem. Biophys. 163, 349–358 (1974)
Wollemann, M., Borbola, J., Jr., Papp, J.G., Szekeres, L.: Cardiac adenylate cyclase activity in relation to beta-adrenergic responses. J. Molec. Cell. Cardiol. 7, 523–533 (1975)
Wollenberger, A.: The role of cyclic AMP in the adrenergic control of myocardium. In: Contraction and relaxation of the heart. Edit.: W.G. Nayler. London: Academic Press 1975, pp. 113–190
Wollenberger, A., Schulze, W.: Cytochemical studies on sarcolemma: Na+,K+-adenosine triphosphatase and adenylate cyclase. Recent Adv. in studies on cardiac structure and metabolism. Vol. 9. The sarcolemma. Edited by P.-E. Roy and N.S. Dhalla. Baltimore: University Park Press 1976, pp. 191–115
Wollenberger, A., Will, H.: Protein kinase-catalyzed membrane phosphorylation and its possible relationship to the role of calcium in the adrenergic regulation of cardiac contraction. Life Sci. 22, 1159–1178 (1978)
Wood, W.G., Lindenmayer, G.E., Schwartz, A.: Myocardial synthesis of ribonucleic acid. I. Stimulation by isoproterenol. J. Molec. Cell. Cardiol. 3, 127–138 (1971)
Wray, H.-L., Gray, R.R.: Cyclic AMP stimulation of membrane phosphorylation and Ca2+- activated, Mg2+-dependent ATPase in cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 461, 441–459 (1977)
Wyborny, L.E., Reddy, Y.S.: Phosphorylated cardiac myofibrils and their effect on ATPase activity. Biochem. Biophys. Res. Commun. 81, 1175–1179 (1978)
Wyngaarden, J.B., Ashton, D.M.: Regulation of activity of phosphoribosylpyrophosphate amidotransferase by purine ribonucleotides: Potential feedback control of purine biosynthesis. J. Biol. Chem. 234, 309–322 (1959)
Yeaman, S.J., Cohen, P.: The specificity of adenosine 3’:5’-cyclic monophosphate-depending protein kinase. Biochem. Soc. Transactions 565 th Meeting, Stirling Vol. 4, 1027–1030 (1977)
Zimmer, H.-G., Gerlach, E.: Effect of beta-adrenergic stimulation on myocardial adenine nucleotide metabolism. Circul. Res. 35, 536–543 (1974)
Zimmer, H.-G., Gerlach, E.: Influence of isoproterenol, propranolol, and D 600 on the de novo synthesis of adenine nucleotides in rat hearts. Recent Adv. in Studies on Cardiac Structure and Metabolism. Vol. 7. Edit. P. Harris, R.J. Bing, A. Fleckenstein. Baltimore: University Park Press 1976, pp. 131–136
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Will-Sahab, L., Krause, E.G. (1980). Effects on Myocardial Metabolism. In: Szekeres, L. (eds) Adrenergic Activators and Inhibitors. Handbook of Experimental Pharmacology, vol 54 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67505-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-67505-8_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67507-2
Online ISBN: 978-3-642-67505-8
eBook Packages: Springer Book Archive